GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Lux Health Tech Acquisition Corp (NAS:LUXA) » Definitions » COGS-to-Revenue

Lux Health Tech Acquisition (Lux Health Tech Acquisition) COGS-to-Revenue : 0.00 (As of Jun. 2022)


View and export this data going back to 2020. Start your Free Trial

What is Lux Health Tech Acquisition COGS-to-Revenue?

Lux Health Tech Acquisition's Cost of Goods Sold for the three months ended in Jun. 2022 was $0.00 Mil. Its Revenue for the three months ended in Jun. 2022 was $0.00 Mil.

Lux Health Tech Acquisition's COGS to Revenue for the three months ended in Jun. 2022 was 0.00.

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin. Lux Health Tech Acquisition's Gross Margin % for the three months ended in Jun. 2022 was N/A%.

Lux Health Tech Acquisition COGS-to-Revenue Historical Data

The historical data trend for Lux Health Tech Acquisition's COGS-to-Revenue can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Lux Health Tech Acquisition COGS-to-Revenue Chart

Lux Health Tech Acquisition Annual Data
Trend Dec20 Dec21
COGS-to-Revenue
- -

Lux Health Tech Acquisition Quarterly Data
Aug20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22
COGS-to-Revenue Get a 7-Day Free Trial - - - - -

Lux Health Tech Acquisition COGS-to-Revenue Calculation

Lux Health Tech Acquisition's COGS to Revenue for the fiscal year that ended in Dec. 2021 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

Lux Health Tech Acquisition's COGS to Revenue for the quarter that ended in Jun. 2022 is calculated as

COGS to Revenue=Cost of Goods Sold / Revenue
=0 / 0
=

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Lux Health Tech Acquisition  (NAS:LUXA) COGS-to-Revenue Explanation

Cost of Goods Sold is directly linked to profitability of the company through Gross Margin.

Lux Health Tech Acquisition's Gross Margin % for the three months ended in Jun. 2022 is calculated as:

Gross Margin %=1 - COGS to Revenue
=1 - Cost of Goods Sold / Revenue
=1 - 0 / 0
=N/A %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A company that has a moat can usually maintain or even expand their Gross Margin. A company can increase its Gross Margin in two ways. It can increase the prices of the goods it sells and keeps its Cost of Goods Sold unchanged. Or it can keep the sales price unchanged and squeeze its suppliers to reduce the Cost of Goods Sold. Warren Buffett believes businesses with the power to raise prices have moats.

Lux Health Tech Acquisition COGS-to-Revenue Related Terms

Thank you for viewing the detailed overview of Lux Health Tech Acquisition's COGS-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Diversified Financial Services » Lux Health Tech Acquisition Corp (NAS:LUXA) » Definitions » COGS-to-Revenue
Comparable Companies
BFAC FRXB GIIX ERES GFX PSPC IVCB WALD SLCR CNDB GSHN PSTH XAMS:EPIC ASZ CCYC CVII KAHC DWAC IPOF PBAJ
Traded in Other Exchanges
N/A
Address
920 Broadway, 11th Floor, New York, NY, USA, 10010
Website
https://www.luxcapital.com
Lux Health Tech Acquisition Corp is a blank check company.
Executives
Frederic H Moll director C/O INTUITIVE SURGICAL INC, 950 KIFER ROAD, SUNNYVALE CA 94086
Joshua Defonzo director, officer: Chief Executive Officer 1500 CORDILLERAS AVENUE, SAN CARLOS CA 94070
Peter Hebert director, 10 percent owner C/O LUX VENTURES, 295 MADISON AVE, 24TH FLOOR, NEW YORK NY 10017
J Robert Kerrey director NEW SCHOOL UNIVERSITY, 66 W. 12TH STREET, NEW YORK NY 10036
Josh Wolfe 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Bijan Salehizadeh director C/O NAVIMED CAPITAL, 1333 H STREET NW, SUITE 400 WEST, WASHINGTON DC 20005
Segolene Scarborough officer: CFO and Treasurer C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Sponsor, Lp 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010
Lux Encore Holdings, Llc 10 percent owner C/O LUX HEALTH TECH ACQUISITION CORP., 920 BROADWAY, 11TH FLOOR, NEW YORK NY 10010

Lux Health Tech Acquisition (Lux Health Tech Acquisition) Headlines

From GuruFocus

Lux Health Tech Acquisition Corp. Announces Closing of $345 Million Initial Public Offering

By Business Wire Business Wire • 10-29-2020

Lux Health Tech Acquisition Corp. Announces the Separate Trading of its Class A Common Stock and Warrants, Commencing December 14, 2020

By Business Wire Business Wire • 12-11-2020